Medical Oxygen Concentrators Market Insights, Competitive Landscape and Market Forecast–2027
Medical Oxygen Concentrators Market By Product (Stationary, Portable), By Technology (Continuous Flow, Pulse Flow, Both), By End-User (Homecare, Hospitals And Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2027 owing to increased prevelence of respiratory disorders like chornic obstructive pulmonary disease (COPD) and increased need for medical oxygen concentrators for geriatrics and bedridden patients
The global medical oxygen concentrators market is estimated to advance at a CAGR of 5.63% during the forecast period (2022-2027). The increase in demand for Medical Oxygen Concentrators is primarily attributed to the increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness, further increased demand in geriatric and bedridden patients, and steep rise in demand of medical oxygen concentrators after COVID-19 pandemic across the world are anticipated to bolster the market, thereby contributing to the growth of the Medical Oxygen Concentrators market during the forecast period from 2022-2027.
Medical Oxygen Concentrators Market Dynamics:
The major factors responsible for product demand is increased prevalence of respiratory disorders like chronic obstructive pulmonary disorder (COPD), sleep apnea, hypoxemia, pulmonary edema and other respiratory illness and increased prevalence of geriatric and bedridden patients.
According to World Health Organization (WHO) 2021, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. Oxygen therapy is needed for COPD to control the oxygen level drops, increasing prevalence of COPD will increase the demand for oxygen concentrators. According to Burden of Obstructive Lung Disease (BOLD) report, 2020, there are nearly three million deaths annually due to COPD. Also as per the same source, COPD is expected to rise over the next 40 years and by 2060 there may be more than 5.4 million deaths annually due to COPD. COPD is increased with increased prevalence of smoking. As per Centers for Disease Control and Prevention, in 2020, nearly 13 of every 100 U.S. adults aged 18 years or older (12.5%) smoked cigarettes. An estimated 30.8 million adults in the United States currently smoke cigarettes and more than 16 million Americans live with a smoking-related disease. This increasing prevalence of smoking shoot up the prevalence of COPD, effecting the market of oxygen concentrators positively.
Moreover, according to the Global Impact of Respiratory Disease report (third edition, published in 2021) published by Forum of International Respiratory Societies, in 2019 more than 100 million people suffer from sleep-disordered breathing. During sleep-disorders like sleep-apnea oxygen therapy is provided to control the oxygen level, which is further expected to increase the demand for medical oxygen concentrators. Stressful lifestyle will also contribute to increase the sleep disorders in young age population during the forecasting period from 2022-2027.
Increase in indoor air pollutants as well as increase in pollution of active smokers, is also responsible for propelling the growth of the medical oxygen concentrator market. The increased exposure to air pollution can cause respiratory ailments in people. According the American Lung Association, 2021 more than four in ten Americans live where the air quality is not good. As per the same source, more than 135 million people live in counties that received an F for either ozone or particle pollution in “State of the Air” 2021.
Also, the prevalence of geriatric and bedridden patients is another factor responsible for the use of these Medical Oxygen Concentrators. According to the Global Initiative for Chronic Obstructive Lung Disease 2020 report, the prevalence of COPD increased steeply with age, with the highest prevalence among those with more than 60 years age. The respiratory system becomes weak with age, lowering the oxygen level in the body.
Dyspnea also known as shortness of breath is highly prevalent in the elderly, and is reported by approximately 30% of individuals greater than 65 years of age. In dyspnea difficulty in breathing is observed as a major symptom, medical oxygen concentrators can be provided to cure this symptom; increasing the market growth of the medical device.
Moreover, according to WHO 2021 report, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22% and by 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
Furthermore, there was more need for oxygen concentrators during COVID-19 infection. During second wave of COVID-19 people purchased oxygen concentrators fearing the shortage of medical oxygen. Moreover, people with COVID-19 were at increased risk for pneumonia and hypoxemia, which are major predictor of mortality. People with these complications were recommended proper oxygen supply. This supply can be given by medical oxygen concentrators. This increased the demand of medical oxygen concentrators in the market. The rise in demand had led to hike in prices.
But, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemic made the resumption of regular healthcare services, which will keep a steady demand for these products on course in the Medical Oxygen Concentrators market.
Therefore, with proper monitoring and care the mortality and hospitalization due to respiratory ailment can be prevented. Hence, the growth of the Medical Oxygen Concentrators Market is expected to rise during the forecast period from 2022 to 2027.
However, the stringent regulatory process and high cost of devices may be certain limiting factors of the Medical Oxygen Concentrators market growth.
Medical Oxygen Concentrators Market Segment Analysis:
Medical oxygen concentrators market by product (stationary, portable), by technology (continuous flow, pulse flow, both), by end-user (homecare, hospitals and clinics, others) and by geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Technology segment of the Medical Oxygen Concentrators market, the Pulse Flow segment is estimated to hold a significant market share in the year 2021. This can be ascribed to the various advantages that are associated with the pulse flow oxygen concentrators.
Pulse flow oxygen concentrators puffs oxygen into the nasal passageway, through a cannula, with each breath. In these concentrators oxygen is delivered only during inhalation and is stored during exhalation thereby saving the amount of oxygen as well as life of battery used to operate the concentrators. This is useful when the patient is doing some other activity like drinking water. These device are mostly used by the patient in daytime as compared to nighttime because the breathing rate is not steady while sleeping.
Furthermore, advantageous properties such as more energy efficiency due to rest period between two breaths, increase in battery life due to rest period and smaller size. As well, doctors’ advice pulse flow oxygen concentrators in moderate to severe respiratory ailments, where these devices are effectively used.
Moreover, various new products are coming into the market which in turn depicts the high demand of these products. For instance, In March 2021, Belluscura announced that the X-PLO2R pulse flow portable oxygen concentrator manufactured by Belluscura has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). X-PLO2R is a compact, quiet, weighing only 3.25 pounds, compact and portable oxygen concentrators.
Therefore, the advantages offered by the Pulse Flow in Medical Oxygen Concentrators are predicted to contribute to the increasing demand, thereby driving the growth of the overall Medical Oxygen Concentrators market during the forecast period.
North America is expected to dominate the overall Medical Oxygen Concentrators Market:
Among all the regions, North America is expected to account for the largest share in the global Medical Oxygen Concentrators market in the year 2021. Factors such as the growing prevalence of various respiratory ailments like COPD, hypoxia and others, increasing prevalence of geriatric and bedridden patients, increase in air pollution and smoking are some of the key factors which are expected to aid in the growth of North America Medical Oxygen Concentrators Market.
For instance, according to the WHO 2021, (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. The mortality rate can be reduced by giving emergency aid to serious patients by the providing medical oxygen concentrators to the patient, increasing the demand of device in the market.
Furthermore, as per the Centers for Disease Control and Prevention (CDC) 2021, COPD makes breathing difficult for the 16 million Americans. The difficulty in breathing can be managed by providing the medical oxygen concentrators to the patients thereby driving the market in North America.
Additionally, according to the Pan American Health Organization (PAHO), in 2019, the chronic respiratory disease accounts for 534,242 deaths in both sexes, 267,516 (50%) deaths in men and 266,725 (50%) in women. The increase in prevalence of chronic respiratory disease and deaths caused by them can be controlled by providing the patients with medical devices like oxygen concentrators and educating them about the usage of the device, will affect the market of the medical device positively.
Moreover, according to CDC, in 2020, preterm birth affected 1 of every 10 infants born in the United States. In preterm birth, organs like lungs, heart, and brain may not be fully developed. If the lungs are not developed properly then external source is used to provide oxygen to the baby. Medical oxygen concentrators can be used to provide oxygen in the above case. The prevalence is expected to rise at a significant rate in the forecast period. Thus, the burgeoning cases of premature births will contribute to the growth of the Medical Oxygen Concentrators market.
Furthermore, the government of the North America is actively involved in relevant organizations which can provide proper COPD management guidance to the patients. National Center for Immunization and Respiratory Diseases is under a mission to prevent the disease, disability, and death through immunization and to control of respiratory and related diseases. As the awareness of treatment and management of COPD will increase in the patient, use of oxygen concentrators will also increases in the market, thereby fostering the market in North America.
Therefore, the rising prevalence of these respiratory disorders in the North America would result in the rising demand for treatments that make use of Medical Oxygen Concentrators, which in turn would provide a conducive growth environment for the Medical Oxygen Concentrators market in the North American region.
Hence, the interplay of various factors such as the presence of a large respiratory ailment patient population, increased prevalence of preterm births in the region as well as awareness created among the patients by government and organizations is expected to boost the North America Medical Oxygen Concentrators market during the forecast period.
Medical Oxygen Concentrators Market Key Players:
Some of the key market players operating in the Medical Oxygen Concentrators market include Koninklijke Philips N.V., Invacare corporation, DeVilbiss Healthcare LLC, Inogen,Inc., Nidek Medical, O2 Concepts, Teijin Limited, Supera Anesthesia Innovations, GCE Group, CAIRE, OxyGo, LLC, Precision medical, Inc., Graham Field, Belluscura , Besco Medical Limited, OSI - Oxygen Solutions Inc, NGK Spark Plug Co Ltd, Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.), Narang Medical Limited, Topson and others.
Recent Developmental Activities in the Medical Oxygen Concentrators Market:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook